Capital World Investors’s Medtronic MDT Stock Holding History

Capital World Investors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.43B	Buy	16,507,316 +9,471,538	+135%	+$907M	0.2%	111
2025 Q4	$676M	Buy	7,035,778 +456,832	+7%	+$44.4M	0.09%	175
2025 Q3	$627M	Buy	6,578,946 +1,061,167	+19%	+$97.5M	0.09%	186
2025 Q2	$481M	Buy	5,517,779 +528,584	+11%	+$44.8M	0.07%	201
2025 Q1	$448M	Buy	+4,989,195	New	+$446M	0.07%	202
2021 Q3	–	Sell	-1,294,375	Closed	-$161M	–	622
2021 Q2	$161M	Buy	1,294,375 +87,784	+7%	+$11M	0.03%	332
2021 Q1	$143M	Buy	1,206,591 +101,242	+9%	+$11.9M	0.03%	329
2020 Q4	$129M	Buy	+1,105,349	New	+$122M	0.03%	323
2019 Q2	–	Sell	-2,093,000	Closed	-$191M	–	545
2019 Q1	$191M	Sell	2,093,000 -1,000,000	-32%	-$89.5M	0.05%	245
2018 Q4	$281M	Sell	3,093,000 -311,000	-9%	-$29.1M	0.08%	196
2018 Q3	$335M	Buy	3,404,000 +312,998	+10%	+$28.9M	0.08%	194
2018 Q2	$265M	Hold	3,091,002	–	–	0.06%	218
2018 Q1	$248M	Sell	3,091,002 -48,925	-2%	-$4.04M	0.06%	222
2017 Q4	$254M	Sell	3,139,927 -4,835,003	-61%	-$387M	0.06%	219
2017 Q3	$620M	Sell	7,974,930 -8,538,761	-52%	-$709M	0.14%	139
2017 Q2	$1.47B	Sell	16,513,691 -6,045,210	-27%	-$510M	0.34%	79
2017 Q1	$1.82B	Sell	22,558,901 -10,633,414	-32%	-$831M	0.43%	63
2016 Q4	$2.36B	Sell	33,192,315 -6,685,274	-17%	-$525M	0.59%	44
2016 Q3	$3.45B	Buy	39,877,589 +65,774	+0.2%	+$5.73M	0.9%	27
2016 Q2	$3.45B	Buy	39,811,815 +1,078,532	+3%	+$87.2M	0.93%	26
2016 Q1	$2.9B	Buy	38,733,283 +7,314,044	+23%	+$551M	0.8%	31
2015 Q4	$2.42B	Sell	31,419,239 -2,742,092	-8%	-$206M	0.68%	37
2015 Q3	$2.29B	Buy	34,161,331 +9,372,074	+38%	+$690M	0.67%	36
2015 Q2	$1.84B	Buy	24,789,257 +428,257	+2%	+$32.7M	0.5%	55
2015 Q1	$1.9B	Buy	24,361,000 +18,797,000	+338%	+$1.42B	0.51%	54
2014 Q4	$402M	Buy	5,564,000 +2,020,000	+57%	+$140M	0.11%	182
2014 Q3	$220M	Buy	3,544,000 +554,000	+19%	+$35.2M	0.06%	235
2014 Q2	$191M	Buy	+2,990,000	New	+$182M	0.05%	242

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors's MDT Position: Q1 2026 in Review

Capital World Investors increased its Medtronic (MDT) stake by 135% in Q1 2026, buying an estimated $907M and bringing the position to 16,507,316 shares worth $1.43B. The position accounts for 0.2% of the portfolio, ranked #111.

Capital World Investors first reported a position in MDT in Q2 2014 and has held it in 28 quarters since. The position peaked at $3.45B in Q2 2016. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Capital World Investors held 16,507,316 shares of Medtronic worth $1.43B as of Q1 2026.
Capital World Investors bought 9,471,538 Medtronic shares in Q1 2026, an estimated $907M.
Medtronic made up 0.2% of Capital World Investors's portfolio in Q1 2026, its #111 holding.
Capital World Investors first reported a position in Medtronic in Q2 2014 and has held it in 28 quarters since.
Capital World Investors's Medtronic position peaked at $3.45B in Q2 2016.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Capital World Investors's 13F filing for Q1 2026, filed 13 May 2026.